UCB, a global biopharmaceutical company, today announced that it is presenting 11 abstracts on bimekizumab in the...
psoriasis
Erica D. Dommasch. Credit: Beth Israel Deaconess Medical Center A common chronic skin condition affecting 125 million...
Researchers have found that treating psoriasis, a chronic inflammatory skin disease, with biologic drugs that target immune...
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that it will be presenting results from...
Almirall, S.A. announced today that the European Commission(EC)has approved ILUMETRI® (tildrakizumab),a humanized, high-affinity IL-23p19 monoclonal antibody, for...
Sun Pharma and its wholly owned subsidiary and Almirall today announced a licensing agreement on the development...
Increasing the level of a naturally-produced protein, called tristetraprolin (TTP), significantly reduced or protected mice from inflammation,...
By the end of the trial, conducted at Rockefeller University and seven other centers, nearly all of...
A man with almost no hair on his body has grown a full head of it after...
Coding variants in immune disease-related genes play only a small part in the overall genetic risk for...